Figure 1: Expression of MYC in myeloma cell lines correlated positively with sensitivity to MYC inhibition. The IC50-values of the MYC inhibitor 10058-F4 calculated from the results shown in Supplementary Figure 2 was compared with A.MYC mRNA values or B. MYC/GAPDH relative protein levels. This evidence concerns the gene GAPDH and plasma cell myeloma.